Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presenting leucocyte count

被引:37
作者
Breccia, M
Carmosino, I
Diverio, D
De Santis, S
De Propris, MS
Romano, A
Petti, MC
Mandelli, F
Lo-Coco, F
机构
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Rome, Italy
[2] Regina Elena Inst Canc Res, Rome, Italy
关键词
acute promyelocytic leukaemia; extramedullary relapse; CNS infiltration; PML; RAR alpha/ATRA;
D O I
10.1046/j.1365-2141.2003.04056.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Extramedullary relapse occurs infrequently in acute promyelocytic leukaemia (APL) but has been increasingly reported after the advent of all-trans retinoic acid (ATRA) treatment, probably as a consequence of improved patient survival. We describe our single centre experience of six APL patients who had disease localization in the central nervous system (CNS). In three patients, clinical symptoms (headache and/or nausea) that presented during follow-up led to the performance of a lumbar puncture and detection of overt CNS infiltration. Two of these patients had simultaneous haematological relapse and one was in molecular remission when CNS leukaemia was documented. One patient with no local symptoms showed CNS infiltration at the time of molecular relapse. Following the introduction of routine lumbar puncture, carried out after front-line induction in all newly diagnosed patients with white blood cell count (WBC) greater than 10 x 10(9)/l, two additional patients in molecular remission with no local symptoms were found to have initial APL localization in the CNS. Presenting features included in 6/6 patients an elevated WBC count (>10 x 10(9) /l) and a predominance of the PML/RAR bcr3 type (5/6 patients) and of microgranular morphology (5/6 patients). Our findings highlight the importance of carrying out lumbar puncture in APL patients presenting with high-risk features.
引用
收藏
页码:266 / 270
页数:5
相关论文
共 21 条
  • [1] Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
    Asou, N
    Adachi, K
    Tamura, J
    Kanamaru, A
    Kageyama, S
    Hiraoka, A
    Omoto, E
    Akiyama, H
    Tsubaki, K
    Saito, K
    Kuriyama, K
    Oh, H
    Kitano, K
    Miyawaki, S
    Takeyama, K
    Yamada, O
    Nishikawa, K
    Takahashi, M
    Matsuda, S
    Ohtake, S
    Suzushima, H
    Emi, N
    Ohno, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 78 - 85
  • [2] Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid:: Result of the randomized MRC trial
    Burnett, AK
    Grimwade, D
    Solomon, E
    Wheatley, K
    Goldstone, AH
    [J]. BLOOD, 1999, 93 (12) : 4131 - 4143
  • [3] EXTRAMEDULLARY MYELOID CELL TUMORS IN ACUTE NONLYMPHOCYTIC LEUKEMIA - A CLINICAL REVIEW
    BYRD, JC
    EDENFIELD, WJ
    SHIELDS, DJ
    DAWSON, NA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1800 - 1816
  • [4] ACUTE PROMYELOCYTIC LEUKEMIA - FROM CLINIC TO MOLECULAR-BIOLOGY
    CHEN, SJ
    WANG, ZY
    CHEN, Z
    [J]. STEM CELLS, 1995, 13 (01) : 22 - 31
  • [5] DINOTO R, 1994, LEUKEMIA, V8, pS71
  • [6] Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid
    Evans, G
    Grimwade, D
    Prentice, HG
    Simpson, N
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) : 437 - 439
  • [7] A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia
    Fenaux, P
    Chastang, C
    Chevret, S
    Sanz, M
    Dombret, H
    Archimbaud, E
    Fey, M
    Rayon, C
    Huguet, F
    Sotto, JJ
    Gardin, C
    Makhoul, PC
    Travade, P
    Solary, E
    Fegueux, N
    Bordessoule, D
    San Miguel, J
    Link, H
    Desablens, B
    Stamatoullas, A
    Deconinck, E
    Maloisel, F
    Castaigne, S
    Preudhomme, C
    Degos, L
    [J]. BLOOD, 1999, 94 (04) : 1192 - 1200
  • [8] Fenaux P, 1997, SEMIN ONCOL, V24, P92
  • [9] CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy
    Ferrara, F
    Morabito, F
    Martino, B
    Specchia, G
    Liso, V
    Nobile, F
    Boccuni, P
    Di Noto, R
    Pane, F
    Annunziata, M
    Schiavone, EM
    De Simone, M
    Guglielmi, C
    Del Vecchio, L
    Lo Coco, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1295 - 1300
  • [10] Immunophenotype of adult and childhood acute promyelocytic leukaemia:: correlation with morphology, type of PML gene breakpoint and clinical outcome.: A cooperative Italian study on 196 cases
    Guglielmi, C
    Martelli, MP
    Diverio, D
    Fenu, S
    Vegna, ML
    Cantù-Rajnoldi, A
    Biondi, A
    Cocito, MG
    Del Vecchio, L
    Tabilio, A
    Avvisati, G
    Basso, G
    Lo Coco, F
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (04) : 1035 - 1041